{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:18:53Z","timestamp":1790864333513,"version":"4.1.0"},"reference-count":50,"publisher":"The Endocrine Society","issue":"7","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH HSN27500006"],"award-info":[{"award-number":["NIH HSN27500006"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN27500003"],"award-info":[{"award-number":["HHSN27500003"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54HD042454-06"],"award-info":[{"award-number":["U54HD042454-06"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.1210\/jc.2018-01882","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T14:10:16Z","timestamp":1549894216000},"page":"2490-2500","source":"Crossref","is-referenced-by-count":103,"title":["Diagnosis and Management of Anabolic Androgenic Steroid Use"],"prefix":"10.1210","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2652-4032","authenticated-orcid":false,"given":"Bradley D","family":"Anawalt","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2019,2,11]]},"reference":[{"issue":"11-12","key":"2019051419194319600_B1","doi-asserted-by":"crossref","first-page":"678","DOI":"10.5694\/j.1326-5377.2002.tb05014.x","article-title":"Brown-S\u00e9quard revisited: a lesson from history on the placebo effect of androgen treatment","volume":"177","author":"Cussons","year":"2002","journal-title":"Med J Aust"},{"issue":"2","key":"2019051419194319600_B2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4103\/1008-682X.122358","article-title":"Testosterone deficiency: a historical perspective","volume":"16","author":"Nieschlag","year":"2014","journal-title":"Asian J Androl"},{"key":"2019051419194319600_B3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mce.2017.02.039","article-title":"History and epidemiology of anabolic androgens in athletes and non-athletes","volume":"464","author":"Kanayama","year":"2018","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"2019051419194319600_B4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199607043350101","article-title":"The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men","volume":"335","author":"Bhasin","year":"1996","journal-title":"N Engl J Med"},{"issue":"1","key":"2019051419194319600_B5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s40279-014-0247-x","article-title":"Prevalence of doping use in elite sports: a review of numbers and methods","volume":"45","author":"de Hon","year":"2015","journal-title":"Sports Med"},{"issue":"5","key":"2019051419194319600_B6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.annepidem.2014.01.009","article-title":"The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis","volume":"24","author":"Sagoe","year":"2014","journal-title":"Ann Epidemiol"},{"key":"2019051419194319600_B7","article-title":"A national study of substance use behaviors among NCAA male athletes who use banner performance enhancing substances","author":"Buckman"},{"issue":"11","key":"2019051419194319600_B8","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/bjsports-2012-091826","article-title":"Would they dope? Revisiting the Goldman dilemma","volume":"47","author":"Connor","year":"2013","journal-title":"Br J Sports Med"},{"issue":"2","key":"2019051419194319600_B9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000333037","article-title":"Anabolic androgenic steroids in the general population: user characteristics and associations with substance use","volume":"18","author":"Hakansson","year":"2012","journal-title":"Eur Addict Res"},{"key":"2019051419194319600_B10","unstructured":"The University of Michigan Institute for Social Research. Monitoring the future. National survey results on drug use. Available at: http:\/\/monitoringthefuture.org\/pubs\/monographs\/mtf-overview2017.pdf. Accessed 1 August 2018."},{"issue":"9","key":"2019051419194319600_B11","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.3109\/10826084.2014.903750","article-title":"Prevalence of the use of anabolic-androgenic steroids in Brazil: a systematic review","volume":"49","author":"Abrahin","year":"2014","journal-title":"Subst Use Misuse"},{"issue":"4","key":"2019051419194319600_B12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1521-0391.2013.12118.x","article-title":"The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates","volume":"23","author":"Pope","year":"2014","journal-title":"Am J Addict"},{"issue":"3","key":"2019051419194319600_B13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/0049124104268664","article-title":"Meta-analysis of randomized response research: thirty-five years of validation","volume":"33","author":"Lensvelt-Mulders","year":"2005","journal-title":"Sociol Methods Res"},{"issue":"1","key":"2019051419194319600_B14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s40279-017-0765-4","article-title":"Doping in two elite athletics competitions assessed by randomized-response surveys","volume":"48","author":"Ulrich","year":"2018","journal-title":"Sports Med"},{"issue":"5","key":"2019051419194319600_B15","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1210\/jc.2005-2569","article-title":"Clinical review: the rationale for banning human chorionic gonadotropin and estrogen blockers in sport","volume":"91","author":"Handelsman","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019051419194319600_B16","first-page":"534","article-title":"the use and abuse of anabolic-androgenic steroids in sports","volume":"19","year":"1987","journal-title":"Med Sci Sports Exerc"},{"issue":"6","key":"2019051419194319600_B17","doi-asserted-by":"crossref","first-page":"E1172","DOI":"10.1152\/ajpendo.2001.281.6.E1172","article-title":"Testosterone dose-response relationships in healthy young men","volume":"281","author":"Bhasin","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"2019051419194319600_B18","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1210\/jc.2004-1184","article-title":"Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle","volume":"90","author":"Bhasin","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019051419194319600_B19","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/GME.0000000000000093","article-title":"Testosterone dose-response relationships in hysterectomized women with or without oophorectomy: effects on sexual function, body composition, muscle performance and physical function in a randomized trial","volume":"21","author":"Huang","year":"2014","journal-title":"Menopause"},{"key":"2019051419194319600_B20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.mce.2017.07.010","article-title":"Do anabolic-androgenic steroids have performance-enhancing effects in female athletes","volume":"464","author":"Huang","year":"2018","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"2019051419194319600_B21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1210\/er.2013-1058","article-title":"Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement","volume":"35","author":"Pope","year":"2014","journal-title":"Endocr Rev"},{"issue":"4","key":"2019051419194319600_B22","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00213-015-4193-6","article-title":"Mad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviors","volume":"233","author":"Onakomaiya","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"issue":"5","key":"2019051419194319600_B23","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/add.12850","article-title":"Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem","volume":"110","author":"Kanayama","year":"2015","journal-title":"Addiction"},{"issue":"8","key":"2019051419194319600_B24","doi-asserted-by":"crossref","first-page":"e0161208","DOI":"10.1371\/journal.pone.0161208","article-title":"Former abusers of anabolic androgenic steroids exhibit decreased testosterone levels and hypogonadal symptoms years after cessation: a case-control study","volume":"11","author":"Rasmussen","year":"2016","journal-title":"PLoS One"},{"issue":"9","key":"2019051419194319600_B25","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1007\/s40279-017-0709-z","article-title":"Effects of anabolic androgenic steroids on the reproductive system of athletes and recreational users: a systematic review and meta-analysis","volume":"47","author":"Christou","year":"2017","journal-title":"Sports Med"},{"issue":"5","key":"2019051419194319600_B26","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.fertnstert.2014.02.002","article-title":"Anabolic steroid-induced hypogonadism: diagnosis and treatment","volume":"101","author":"Rahnema","year":"2014","journal-title":"Fertil Steril"},{"issue":"6","key":"2019051419194319600_B27","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/JSM.0b013e3181fb5370","article-title":"Women and anabolic steroids: an analysis of a dozen users","volume":"20","author":"Ip","year":"2010","journal-title":"Clin J Sport Med"},{"issue":"1","key":"2019051419194319600_B28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000012362","article-title":"Psychiatric and medical effects of anabolic-androgenic steroid use in women","volume":"69","author":"Gruber","year":"2000","journal-title":"Psychother Psychosom"},{"issue":"1","key":"2019051419194319600_B29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1570159X13666141210222725","article-title":"Anabolic-androgenic steroid use and psychopathology in athletes. A systematic review","volume":"13","author":"Piacentino","year":"2015","journal-title":"Curr Neuropharmacol"},{"issue":"Pt 1","key":"2019051419194319600_B30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.brainresbull.2016.05.003","article-title":"The neurobiology and addiction potential of anabolic androgenic steroids and the effects of growth hormone","volume":"126","author":"Gr\u00f6nbladh","year":"2016","journal-title":"Brain Res Bull"},{"issue":"21","key":"2019051419194319600_B31","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1161\/CIRCULATIONAHA.116.026945","article-title":"Cardiovascular toxicity of illicit anabolic-androgenic steroid use","volume":"135","author":"Baggish","year":"2017","journal-title":"Circulation"},{"issue":"11","key":"2019051419194319600_B32","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1206168","article-title":"Gonadal steroids and body composition, strength, and sexual function in men","volume":"369","author":"Finkelstein","year":"2013","journal-title":"N Engl J Med"},{"issue":"11","key":"2019051419194319600_B33","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1177\/0363546515602010","article-title":"Ruptured tendons in anabolic-androgenic steroid users: a cross-sectional cohort study","volume":"43","author":"Kanayama","year":"2015","journal-title":"Am J Sports Med"},{"key":"2019051419194319600_B34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mce.2017.09.027","article-title":"Detection of anabolic androgenic steroid use by elite athletes and by members of the general public","volume":"464","author":"Anawalt","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"2019051419194319600_B35","article-title":"Data breaches keep happening. So why don't you do something","author":"Mele","year":"1, 2018","journal-title":"New York Times"},{"issue":"9","key":"2019051419194319600_B36","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1210\/jc.2012-2400","article-title":"Approach to male infertility and induction of spermatogenesis","volume":"98","author":"Anawalt","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019051419194319600_B37","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ogc.2012.09.001","article-title":"Infertility evaluation","volume":"39","author":"McLaren","year":"2012","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"9520","key":"2019051419194319600_B38","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0140-6736(06)68614-5","article-title":"Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis","volume":"367","author":"Liu","year":"2006","journal-title":"Lancet"},{"issue":"5","key":"2019051419194319600_B39","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1210\/jc.2003-031307","article-title":"Male hormonal contraception: effects of injections of testosterone undecanoate and depot medroxyprogesterone acetate at eight-week intervals in chinese men","volume":"89","author":"Gu","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019051419194319600_B40","first-page":"757","article-title":"Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach","volume":"81","author":"Bebb","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019051419194319600_B41","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0015-0282(16)58221-1","article-title":"Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men","volume":"65","author":"World Health Organization Task Force on Methods for the Regulation of Male Fertility","year":"1996","journal-title":"Fertil Steril"},{"issue":"5","key":"2019051419194319600_B42","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/bju.14401","article-title":"Clomiphene citrate and human chorionic gonadotropin are both effective in restoring testosterone in hypogonadism: a short-course randomized study","volume":"122","author":"Habous","year":"2018","journal-title":"BJU Int"},{"issue":"10","key":"2019051419194319600_B43","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/j.1464-410X.2012.10968.x","article-title":"Clomiphene citrate is safe and effective for long-term management of hypogonadism","volume":"110","author":"Moskovic","year":"2012","journal-title":"BJU Int"},{"issue":"4","key":"2019051419194319600_B44","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1464-410X.2011.10702.x","article-title":"Outcomes of clomiphene citrate treatment in young hypogonadal men","volume":"110","author":"Katz","year":"2012","journal-title":"BJU Int"},{"issue":"1 Pt 1","key":"2019051419194319600_B45","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1743-6109.2009.01454.x","article-title":"Clomiphene citrate and testosterone gel replacement therapy for male hypogonadism: efficacy and treatment cost","volume":"7","author":"Taylor","year":"2010","journal-title":"J Sex Med"},{"issue":"8","key":"2019051419194319600_B46","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1055\/s-0032-1328883","article-title":"The adverse effects of estrogen and selective estrogen receptor modulators on hemostasis and thrombosis","volume":"38","author":"Artero","year":"2012","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"2019051419194319600_B47","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/gtmb.2008.0104","article-title":"Central retinal vein occlusion secondary to clomiphene treatment in a male carrier of factor V Leiden","volume":"13","author":"Politou","year":"2009","journal-title":"Genet Test Mol Biomarkers"},{"key":"2019051419194319600_B48","doi-asserted-by":"crossref","first-page":"bcr2016217403","DOI":"10.1136\/bcr-2016-217403","article-title":"Intracranial venous thrombosis in a man taking clomiphene citrate","volume":"2016","author":"Zahid","year":"2016","journal-title":"BMJ Case Rep"},{"issue":"1","key":"2019051419194319600_B49","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0015-0282(02)04550-8","article-title":"Use of clomiphene citrate to reverse premature andropause secondary to steroid abuse","volume":"79","author":"Tan","year":"2003","journal-title":"Fertil Steril"},{"issue":"3","key":"2019051419194319600_B50","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/sj.ijir.3900981","article-title":"Clomiphene increases free testosterone levels in men with both secondary hypogonadism and erectile dysfunction: who does and does not benefit","volume":"15","author":"Guay","year":"2003","journal-title":"Int J Impot Res"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/104\/7\/2490\/28646980\/jc.2018-01882.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T12:27:21Z","timestamp":1573907241000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/104\/7\/2490\/5310131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,11]]},"references-count":50,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,2,11]]},"published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2018-01882","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,7]]},"published":{"date-parts":[[2019,2,11]]}}}